Thursday, April 30, 2020

GALT: Galectin Therapeutics Submits Seamless Adaptively-Designed Phase 2b/3 NASH-RX Protocol in NASH Cirrhosis

New alert via PocketInfo for GALT:

Galectin Therapeutics Submits Seamless Adaptively-Designed Phase 2b/3 NASH-RX Protocol in NASH Cirrhosis

Press Releases: http://phx.corporate-ir.net/phoenix.zhtml?c=135403&p=irol-news&nyo=0
SEC Filings: http://phx.corporate-ir.net/phoenix.zhtml?c=135403&p=irol-sec
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8

No comments:

Post a Comment